Shandong New Time Pharmaceutical Co., Ltd.
Shandong New Time Pharmaceutical Co., Ltd., commonly referred to as New Time Pharma, is a leading player in the pharmaceutical industry, headquartered in Shandong, China. Established in 2003, the company has rapidly expanded its operations across various regions, focusing on the development and manufacturing of high-quality pharmaceutical products. Specialising in active pharmaceutical ingredients (APIs) and finished dosage forms, New Time Pharma is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of generic medications and specialty pharmaceuticals, distinguished by their efficacy and safety profiles. With a strong market presence, Shandong New Time Pharmaceutical has achieved significant milestones, including certifications from international regulatory bodies, which underscore its dedication to maintaining the highest industry standards. As a trusted partner in healthcare, New Time Pharma continues to contribute to global health advancements through its cutting-edge solutions.
DitchCarbon Score
How does Shandong New Time Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shandong New Time Pharmaceutical Co., Ltd.'s score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shandong New Time Pharmaceutical Co., Ltd.'s reported carbon emissions
Shandong New Time Pharmaceutical Co., Ltd., headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). As a result, there are no significant achievements or targets to highlight regarding their carbon footprint or climate commitments. The lack of emissions data and reduction initiatives suggests that Shandong New Time Pharmaceutical may not yet be actively engaged in formal climate action or reporting practices. In the broader context of the pharmaceutical industry, companies are increasingly expected to adopt transparent climate strategies and set measurable targets to reduce their environmental impact. However, without specific data or commitments, it is challenging to assess Shandong New Time Pharmaceutical's position in this evolving landscape.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shandong New Time Pharmaceutical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
